Name another biotech with the IP portfolio that XXII has for tobacco (as well as hand in hemp/cannabis) which is actually a MSA participating manufacture of it's own propriety commercial high and low nicotine cigarettes, that is applying to have potentially the first FDA modified risk labeling on it's product in the US, and is in Europe as well. And since XXII has a virtual monopoly around the tobacco plant the Government is actually buying cigarettes in order to do nicotine research and has been for years. British American Tobacco researched the Company for over a year and liked what it saw. The tobacco industry is approximately an $800B industry and if you don't see the value in a microcap with that potential currently valued under $100M, that is a shame. BTW if you're buying this stock because of a price target, that is a shame as well. It is also unreasonable to expect a company to hold your hand as an investors and provide weekly updates. There is always risk in investing and you must do things to protect your bottom line, but as far as XXII, which has only 2 quarters of commercial production under it's belt, the risk/reward greatly favors reward right now in IMO. I do not see much in the way that can prevent XXII from eventually becoming a big success.
Speaking of success, the current CEO actually has experience in growing a tobacco co which was eventually sold to Big Tobacco. Interestingly enough Henry's former co, American Spirit, which was sold to Reynolds American, is in turn 42% owned by British American Tobacco, hmm. Also, let's look back and what has been accomplished since the former CEO's departure:
June 17, 2015
Phase II Clinical Trial Featuring 22nd Century's Very Low Nicotine Tobacco Accepted for Publication (via Business Wire)
June 15, 2015
22nd Century Group Obtains Cigarette Distribution Licenses in New York State (via Business Wire)
May 28, 2015
22nd Century Announces Launch of "0.0 mg Nicotine" MAGIC Cigarettes in the United Kingdom (via Business Wire)
May 26, 2015
22nd Century Launches Powerful Consumer Marketing Initiative (via Business Wire)
May 22, 2015
22nd Century Group Appoints Nora B. Sullivan to Board of Directors (via Business Wire)
May 21, 2015
22nd Century Group Signs Contract with Rich & Rhine (via Business Wire)
May 11, 2015
22nd Century Group Files First Quarter 2015 Financial Results And Announces Conference Call to Provide Business Update (via Business Wire)
April 28, 2015
22nd Century Group Provides Highlights from Annual Shareholder Meeting (via Business Wire)
April 16, 2015
22nd Century Group Announces Launch of "0.0 mg Nicotine" MAGIC Cigarettes in Spain (via Business Wire)
March 25, 2015
Professor David Sweanor to Give Keynote Address at 22nd Century Group Annual Shareholder Meeting; Company Releases Letter to Shareholders (via Business Wire)
February 06, 2015
22nd Century Group Files 2014 Annual Report And Announces Conference Call to Provide Business Update (via Business Wire)
January 22, 2015
22nd Century Group Announces First Shipment of Smoker Friendly Private Label Cigarettes (via Business Wire)
January 20, 2015
22nd Century Group Announces First Shipments of RED SUN Cigarettes
